Application of Volumetric Absorptive Micro Sampling to Measure Multidimensional Anti-Influenza Hemagglutinin IgG Antibodies by mPlex-Flu Assay
J. Wang, D. Li, A. Wiltse, J. Emo, S. P. Hilchey, M. S. Zand
Abstract
Recently, volumetric absorptive microsampling (VAMS) has been used for peripheral blood sampling and analyses in several fields. VAMS ensures accurate sampling by collecting a fixed blood volume (10 or 20 {micro}L) on a volumetric swab in blood spot format, and allows for long-term sample storage. The mPlex-Flu assay is a novel, multidimensional assay that measures the concentration of antibodies against multiple influenza virus hemagglutinins simultaneously strains with a small volume of serum (less than 5 {micro}L). Here we describe combining these two methods to measure multidimensional influenza antibody activity using a finger-stick and VAMS. In this study, we compared influenza antibody profiles measured from capillary blood obtained with a finger-stick, and venous whole blood collected by traditional phlebotomy from 20 subjects using the mPlex-Flu assay. We found that results with the two sampling methods were virtually identical across all influenza strains within the same subject (mean of R2 =0.9470), and that antibodies remained stable over three weeks when VAMS samples were stored at room temperature and transported using a variety of shipping methods. Additionally, VAMS sampling is an easy and highly reproducible process; when volunteers performed finger stick VAMS at home by themselves, the results of anti-HA antibody concentrations showed that they are highly consistent with sampling performed by study personnel on-site (R2 =0.9496). This novel approach provides advantages for clinical influenza vaccine studies, including ease of sampling, low cost, and high accuracy. We conclude that these methods could provide an accurate and low-cost means for monitoring the influenza virus antibody responses in large population studies.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A rapid and flexible microneutralization assay for serological assessment of influenza viruses
K. E. Rumfelt, W. J. Fitzsimmons, … A. S. Lauring·bioRxiv·Feb 2, 2023
- Impact of serum versus anticoagulant-containing plasma on influenza virusneuraminidase-based serological assays
Thi Hoai Thu Do, Stephen John Kent, … Marios Koutsakos·VaccinePeer-reviewed·Nov 13, 2025
- Antibodies to influenza A virus hemagglutinin and neuraminidase limit egress and alter the physical properties of released virus particles
Anna Jaeggi-Wong, Antonio Santos‐Peral, … Tijana Ivanovic·bioRxiv·Jun 15, 2026
- Establishment of pan-Influenza A (H1-H18) and pan-Influenza B (pre-split, Vic/Yam) Pseudotype Libraries for efficient vaccine antigen selection
J. M. Del Rosario, K. da Costa, … N. J. Temperton·bioRxiv·May 20, 2021
- Development and use of Lentiviral Vectors Pseudotyped with Influenza B Haemagglutinins: application to vaccine immunogenicity, mAb potency and sero-surveillance studies
Francesca Ferrara, George Carnell, … Nigel J Temperton·bioRxiv·Dec 10, 2018
- Model-based inference of neutralizing antibody avidities against influenza virus
J. Linnik, M. Syedbasha, … J. Stelling·bioRxiv·Oct 5, 2020